Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Board Changes

12 Dec 2008 11:00

RNS Number : 0326K
Gleeson(M J)Group PLC
12 December 2008
 



12 December 2008

M J GLEESON GROUP PLC

Board Changes

Resignation of Paul Wallwork as Group Chief Executive

Gleeson (GLE.L), the urban regeneration and strategic land specialist, announces the resignation of Paul Wallwork as Group Chief Executive with effect from 31 December 2008

Paul Wallwork, ACA, BA (Hons), 46, was appointed to the Board in January 2006 as Group Finance Director. He was appointed Group Chief Executive in January 2007 having previously served as Interim Group Chief Executive since July 2006. He previously held senior financial and management roles with Inchcape plc and senior financial roles with Brent International plc.

Dermot Gleeson, Non-executive Chairman, stated "I would like to thank Paul for his strong and energetic leadership of the Gleeson Group through an extremely challenging period. He has ensured that the Group is well placed to meet the tough challenges faced by all housebuilders in the current market conditions."

Appointment of Group Chief Executive

Gleeson is pleased to announce the appointment as Group Chief Executive, with effect from 1 January 2009, of Chris Holt who, since 1 May 2007, has been Group Finance Director and prior to that held the position of Interim Group Finance Director from August 2006.

Nicholas Christopher Holt, BSc, MBA, CIMA, 57, has obtained a wealth of financial and management experience at senior level with internationally renowned businesses, namely Foster Wheeler (1987-2005) and Bechtel (1975-87). 

Dermot Gleesonstated "As Group Finance Director, Chris has made a hugely important contribution to the successful restructuring of the Group, and his skills and experience mean that he is very well equipped to provide the effective leadership that Gleeson will continue to need in an exceptionally difficult economic environment."

Appointment of Group Finance Director

To replace Chris Holt, Gleeson is pleased to announce the appointment of Alan Martin as Group Finance Director with effect from 1 January 2009. Alan is currently Group Financial Controller, a position he has held since November 2006.

Alan Martin, BSc (Hons), ACA, 42, qualified as a Chartered Accountant in 1990, following which he joined Price Waterhouse where he specialised in corporate recovery in both London and SydneyAustralia. Assignments included secondment as Advisor to National Australia Bank. In 2000, he joined Psion PLC, where he held a number of senior management roles, the most recent being Group Financial Controller.

Alan Martin has held no directorship in any other publicly quoted company at any time in the previous five years and there are no details to be disclosed under paragraph 9.6.13 R of the Listing Rules.

Dermot Gleeson stated "I am delighted that Alan has joined the Board to which he has the potential to make an extremely valuable contribution." 

Enquiries:

M J Gleeson Group plc 01252 360300

Chris Holt (Group Chief Executive, Designate)

Alan Martin (Group Finance Director, Designate)

Bankside Consultants Limited

Charles Ponsonby  020 7367 8851

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFKBKNKBDDFBD
Date   Source Headline
25th Mar 20204:35 pmRNSPrice Monitoring Extension
25th Mar 20203:38 pmRNSCovid-19 Update
23rd Mar 20204:40 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:36 pmRNSPrice Monitoring Extension
13th Mar 202012:08 pmRNSSecond Price Monitoring Extn
13th Mar 202012:02 pmRNSPrice Monitoring Extension
9th Mar 20209:49 amRNSDirector/PDMR Shareholding
28th Feb 20207:00 amRNSTotal Voting Rights
13th Feb 202012:02 pmRNSPrice Monitoring Extension
13th Feb 20207:00 amRNSHalf-year Report
10th Feb 20202:32 pmRNSDirector/PDMR Shareholding
31st Jan 20207:00 amRNSTotal Voting Rights
9th Jan 20207:00 amRNSNotice of Results and Trading Update
8th Jan 20206:05 pmRNSDirector/PDMR Shareholding
31st Dec 20197:00 amRNSTotal Voting Rights
20th Dec 20196:09 pmRNSExercise of options, PDMR Dealing and TVR
19th Dec 201912:07 pmRNSSecond Price Monitoring Extn
19th Dec 201912:02 pmRNSPrice Monitoring Extension
18th Dec 201910:15 amRNSDirector/PDMR Shareholding
11th Dec 20195:22 pmRNSPerformance Share Plan award to Directors/PDMRs
9th Dec 201911:31 amRNSDirector/PDMR Shareholding
5th Dec 20193:18 pmRNSResult of AGM
5th Dec 20197:00 amRNSAGM Statement
3rd Dec 20194:07 pmRNSTotal Voting Rights
2nd Dec 20197:01 amRNSIncentive Plan Share Issue
2nd Dec 20197:00 amRNSAppointment of Chief Executive Officer
29th Nov 20197:00 amRNSTotal Voting Rights
12th Nov 20193:40 pmRNSPerformance Share Plan award to Directors/PDMRs
11th Nov 201910:12 amRNSDirector/PDMR Shareholding
4th Nov 20197:00 amRNSNotice of AGM
31st Oct 201912:13 pmRNSRe Committee Appointments
31st Oct 20197:00 amRNSTotal Voting Rights
16th Oct 20193:58 pmRNSHolding(s) in Company
9th Oct 201912:05 pmRNSDirector/PDMR Shareholding
9th Oct 201911:46 amRNSDirector/PDMR Shareholding
8th Oct 20192:09 pmRNSExercise of Options and Total Voting Rights
30th Sep 20197:00 amRNSTotal Voting Rights
24th Sep 20197:00 amRNSAppointment of Non-Executive Directors
24th Sep 20197:00 amRNSDirector/PDMR Shareholding
16th Sep 20197:00 amRNSFinal Results
10th Sep 20195:35 pmRNSDirector/PDMR Shareholding
30th Aug 20197:00 amRNSTotal Voting Rights
14th Aug 20194:35 pmRNSPrice Monitoring Extension
8th Aug 20199:32 amRNSDirector/PDMR Shareholding
7th Aug 20191:40 pmRNSHolding(s) in Company
31st Jul 20197:00 amRNSTotal Voting Rights
11th Jul 201910:55 amRNSDirector/PDMR Shareholding
4th Jul 20197:00 amRNSTrading Update
28th Jun 20197:00 amRNSTotal Voting Rights
10th Jun 20192:16 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.